For laboratory research use only - not for human consumption

Hub ยท Peptide Science

Solid-phase peptide synthesis: principle, limits and quality testing

Solid-phase peptide synthesis (SPPS) builds a peptide chain one amino acid at a time while the growing chain stays covalently anchored to an insoluble polymer resin bead. Because the resin-bound chain is not purified between steps, crude products can carry deletion sequences, truncated chains and chemical modifications. Published guidance notes that verifying a purified synthetic peptide calls for independent analytical methods beyond a single HPLC check.

Published 2026-11-19Updated 2026-11-19Written by Form Laboratories research team6 min read

Picture threading beads onto a string whose far end is tied to a workbench. After each bead goes on, you can rinse away loose pieces without losing the string. Solid-phase peptide synthesis works on that idea, except the string is a growing chain of amino acids and the workbench is a tiny crosslinked polymer bead swollen with solvent.

This page is part of the peptide science hub. It summarises a 2025 perspective essay by Stephen Kent on how solid-phase synthesis works, why by-products build up during chain assembly, and what those limits mean for analytical testing. It is research reference material, for research use only. It gives no synthesis protocol and makes no claim about how any Form Laboratories product was made.

  • Guidethe peptide science hubPeptide science questions answered from published studies and regulator records: what peptides are, which are approved in Australia and by the FDA, and where research peptides sit.

Key facts

Key facts for Solid-phase peptide synthesis: principle, limits and quality testing
What SPPS isStepwise chemical assembly of a peptide chain covalently anchored to an insoluble resin support
Introduced byBruce Merrifield, 1963 (cited in Kent, 2025)
Typical resin supportCrosslinked copolymer of styrene and 1% meta-divinylbenzene (S-DVB), around 50 micrometre beads
Assembly directionFrom the C-terminal amino acid towards the N-terminus to minimise racemisation
Common protecting chemistryFmoc chemistry (base-removable N-alpha group, acid-labile side-chain groups); Boc chemistry now rarer
Main crude by-productsDeletion sequences, truncated chains (terminations) and covalent modifications
Analytical verification principleAt least two high-resolution methods on separation principles distinct from purification, plus sequence confirmation (Kent, 2025)
SourceKent SBH, Journal of Peptide Science, 2025;31(5):e70013
Manufacturing claims for Form Laboratories productsNone on this page
UseResearch reference material. Not for human or animal use
Journal of Peptide Science 2025

What is the principle of solid-phase peptide synthesis?

Solid-phase peptide synthesis builds a peptide by forming peptide bonds one amino acid at a time while the chain remains covalently attached to an insoluble resin support. Bruce Merrifield introduced this method in 1963. The C-terminal amino acid of the target sequence is anchored to crosslinked polymer beads, most commonly a copolymer of styrene and 1% meta-divinylbenzene (S-DVB) fractionated to about 50 micrometres in diameter. Subsequent residues are added towards the N-terminus to minimise racemisation, using temporary alpha-amino protection, carboxyl activation and semi-permanent side-chain protection.

Kent notes that the near-universal adoption of SPPS rests on more than simple filtration washes, quantitative recovery of the resin-bound chain at each cycle and ease of automation. In organic solvents, S-DVB beads swell to three to five times their dry volume, and chain assembly happens inside the solvent-swollen polymer network.

Because the resin polymer and the protected peptide chains are chemically dissimilar and the polymer crosslinks prevent phase separation, resin-bound protected chains show enhanced solvation compared with protected chains in free solution. Fmoc chemistry, which removes the N-alpha fluorenylmethyloxycarbonyl group under basic conditions while keeping acid-labile side-chain protection, is now the most widely used version; Boc chemistry, based on graduated acid lability, was once dominant and is now more rarely used.

  • Guidepeptide bondsA peptide bond is the amide link that joins two amino acids. How it forms, where it sits, how to count bonds, which foods contain them, and what synthetic peptides and peptide vaccines are.
Journal of Peptide Science 2025

What are the main limitations and by-products of stepwise SPPS?

Because stepwise SPPS does not purify the resin-bound peptide between coupling cycles, every resin-bound side reaction accumulates until the finished chain is cleaved from the support. Kent reports that in stepwise synthesis of chains containing roughly 15 or more amino acids, large numbers of low-level by-products form, and their combined amount often exceeds the amount of target peptide in the crude product. These by-products include deletion sequences (missing one or more internal residues), truncated sequences or terminations (shorter chains with free or blocked N-termini), and covalent chemical modifications.

Covalent modifications formed during chain assembly include isobaric isomerisations such as N-to-O acyl shifts and racemisation, which share the same molecular mass as the target chain, as well as mass-shifting changes such as succinimide ring formation and hydrolysis of amide side chains. Because most of these by-products closely resemble the target peptide in structure and chromatographic behaviour, purifying the crude mixture is demanding.

Kent also highlights chemical efficiency limits in conventional Fmoc SPPS. The Fmoc protecting group alone is roughly twice the average amino acid residue mass, so only about one-third of a typical Fmoc-amino acid ends up in the target chain, and a three- to five-fold excess of each protected amino acid is commonly used to drive coupling. Solvent waste during chain assembly and preparative reverse-phase HPLC purification produces high process mass intensity. For chains longer than around 35 to 40 residues, Kent recommends convergent synthesis by native chemical ligation of purified unprotected segments rather than stepwise SPPS alone.

For how synthesis-derived by-products sit alongside degradation and non-peptide impurities in regulatory categories, see the types of peptide impurities page.

  • Guidethe types of peptide impurities pageThe main categories of impurity in a synthetic peptide: sequence-related, degradation products and non-peptide material, and why different tests look for different categories. Cited to the EMA guideline.
Journal of Peptide Science 2025

What do SPPS by-products mean for quality testing?

The mix of closely related by-products left by stepwise SPPS directly shapes how a purified synthetic peptide has to be checked. Kent writes that when preparative reverse-phase HPLC is used to purify a synthetic peptide, checking the purified material only by analytical HPLC or analytical LC-MS is not meaningful as proof of homogeneity. Instead, homogeneity should be established with at least two high-resolution analytical methods that rely on distinct separation principles and differ from the method used to purify the sample.

Kent cites direct-infusion electrospray mass spectrometry, which reveals peptide components with masses different from the target, alongside capillary electrophoresis or isoelectric focusing, which separate co-products according to charge. Those orthogonal checks address impurities that can co-elute on the same reverse-phase column.

Kent also stresses that confirming the expected molecular mass by electrospray mass spectrometry is necessary, but not sufficient, to verify covalent structure. Isobaric by-products such as racemised residues or N-to-O acyl shift isomers carry the exact same mass as the intended peptide. Experimental verification of the amino acid sequence, for example by MALDI-TOF mass spectrometry ladder sequencing, is therefore part of establishing covalent identity.

Journal of Peptide Science 2025

Evidence limits

What does this page not show?

This page makes no claim about how any Form Laboratories product was synthesised, purified or tested, and it shows no analytical result for any batch. It is a summary of one published perspective essay on solid-phase peptide synthesis and does not provide a synthesis recipe, reagent amounts or laboratory procedure. Form Laboratories supplies research material for research use only, not for human or animal use.

Kent's 2025 essay is a perspective paper that also proposes a future green-chemistry route combining aqueous N-carboxyanhydride (NCA) SPPS, sample-displacement chromatography and native chemical ligation. The author notes that aqueous NCA SPPS remains at an early proof-of-concept stage and requires further research on NCA sensitivity to moisture and reaction optimisation.

Comparison

Key aspects of stepwise SPPS and analytical verification as summarised in Kent (Journal of Peptide Science, 2025). This table describes the published essay, not any Form Laboratories product.

Comparison: Solid-phase peptide synthesis: principle, limits and quality testing
StageWhat happens in stepwise SPPSLimitation noted in Kent (2025)Testing implication
Chain assembly on resinAmino acids couple one by one from C-terminus to N-terminus inside solvent-swollen S-DVB resin beadsNo intermediate purification; deletions, terminations and side-chain modifications accumulate on the resinCrude material from chains of about 15 or more residues often contains more total by-product than target peptide
Cleavage and purificationSide-chain protecting groups are removed, the peptide is released from the resin, and preparative reverse-phase HPLC separates the crude mixMany by-products share closely similar structures and chromatographic properties with the target chainAnalytical reverse-phase HPLC alone repeats the purification principle and does not by itself establish homogeneity
Post-purification verificationIndependent analytical methods check homogeneity and covalent structureMass confirmation alone misses isobaric isomerisations such as racemisation or N-to-O acyl shiftsKent recommends at least two orthogonal separation methods (such as direct-infusion ESI-MS plus capillary electrophoresis or IEF) and experimental sequence verification

FAQ

What is solid-phase peptide synthesis?

Solid-phase peptide synthesis (SPPS) is the stepwise chemical assembly of a peptide chain while its C-terminal residue stays covalently attached to an insoluble polymer resin bead. Bruce Merrifield introduced the method in 1963, and Fmoc chemistry is currently the most widely used form (Kent, 2025).

Why does SPPS produce deletion and truncated sequences?

In stepwise SPPS, the resin-bound peptide is not purified between coupling cycles. Incomplete additions leave deletion sequences missing one or more internal amino acids, while premature terminations leave shorter truncated chains with free or blocked N-termini. For chains of around 15 or more residues, Kent notes that total crude by-products often exceed the target peptide.

Why is a single HPLC check not enough after reverse-phase HPLC purification?

Kent writes that when preparative reverse-phase HPLC is used to purify a synthetic peptide, checking the product only with analytical HPLC or analytical LC-MS is not meaningful for proving homogeneity. He recommends at least two high-resolution methods based on separation principles different from purification, such as direct-infusion electrospray mass spectrometry and capillary electrophoresis or isoelectric focusing.

Does confirming molecular weight prove a synthetic peptide has the right structure?

No. Kent notes that matching the expected mass by electrospray mass spectrometry is necessary but not sufficient to verify covalent structure, because isobaric by-products such as racemised peptides or N-to-O acyl shift isomers share the same mass. Sequence confirmation is also needed.

Does this page describe how Form Laboratories products are made?

No. This page summarises published scientific literature on solid-phase peptide synthesis for research reference only. It makes no claim about how any Form Laboratories product was manufactured and gives no synthesis recipe. Form Laboratories supplies research material for research use only, not for human or animal use.

Citations

1 sources
  1. Kent SBH. Journal of Peptide Science. 2025;31(5):e70013.
    doi:10.1002/psc.70013

Written by

Form Laboratories research team

Perth, Western Australia. We supply research-use-only reference material.

Written in-house
These articles are written and maintained by our own research team, not by a named clinician.
Built from the record
Every figure comes from published literature, listed in full above with a link to the original paper.
No use directions
We describe what the research measured. We give no use directions, preparation steps or advice.

Form Laboratories supplies research-use-only reference material. This article is an educational summary of published third-party literature. It is not medical advice, not a use instruction, and research material is not for human or animal use.

2026 Form Laboratories - Research use only - Perth WAPerth WA 6000 - dispatched Australia-wide via Australia Post or CouriersPlease